DAYTON, Ohio (WDTN) – As the CDC determine what to do with the Johnson & Johnson’s vaccine after putting it on pause, some people in the Miami Valley aren’t thrilled about a potential comeback.
“I don’t want anybody to get sick. That’s the devil talking we don’t need that,” said Stacey Lamb. Lamb lives at the St. Vincent DePaul Women’s Center. While she hasn’t received her vaccine yet, she knows she won’t get J&J. “I don’t wanna die. I wanna live. I’m just 32 years old. I want a healthy life,” said Lamb.
The Johnson & Johnson vaccine was paused nationwide after six women suffered blood clots, with one eventually dying as a result. This number, compared to the 7 million people who’d already received a dose, gives an idea of the possibility.
“The blood clot they’re looking at was a very specific one, so it’s a little bit different. So one and ten thousand. Your risk of getting the J&J vaccine is one in 72,000,” said Dr. Joseph Allen, regional medical director at Premier Health.
Ian Robson hasn’t been vaccinated yet, but plans to. While he’d prefer not to get J&J’s vaccine, he’s comfortable with it returning to use.
“I think I’d prefer the Moderna or Pfizer mostly, again also because of the higher percentage. My opinion the double shot seems like it’s more effective than the single dose,” said Robson.
Robson says his family has pre-existing conditions, and he wants to protect himself and others.
“My mom just survived breast cancer, so I want to make sure that at the very least she’s safe when I’m around her so I don’t have to worry so much about her health,” said Robson.
Currently, there’s been no word on if the CDC will approve the continued use of J&J vaccine or when it will be available for use again.